Modelling hospital admissions for lower respiratory tract infections in the elderly in England

B Müller-Pebody, NS Crowcroft, MC Zambon… - Epidemiology & …, 2006 - cambridge.org
Despite the importance of lower respiratory-tract infection (LRI) in causing hospitalizations in
elderly patients ([ges] 65 years of age) and recent advances in vaccine development, a …

[HTML][HTML] Case studies and literature review of pneumococcal septic arthritis in adults

A Dernoncourt, Y El Samad, J Schmidt… - Emerging Infectious …, 2019 - ncbi.nlm.nih.gov
We conducted a retrospective study on all cases of pneumococcal septic arthritis (SA) in
patients> 18 years of age reported to the Picardie Regional Pneumococcal Network in …

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland

K Alexandrova Nikolova, M Andersson, HC Slotved… - Vaccines, 2024 - mdpi.com
Before the incorporation of the 13-valent pneumococcal conjugate vaccine (PCV13) into the
childhood vaccination regimen in Greenland in 2010, Inuit populations experienced a …

Surveillance of Invasive Streptococcus pneumoniaeInfection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial …

LP Jette, G Delage, L Ringuette, R Allard… - Journal of clinical …, 2001 - Am Soc Microbiol
In the province of Quebec, Canada, from 1996 to 1998, 3,650 invasive Streptococcus
pneumoniae infections were reported. A total of 1,354 isolates were serotyped and tested for …

Advances in pneumococcal vaccines: what are the advantages for the elderly?

A Vila-Córcoles - Drugs & aging, 2007 - Springer
Streptococcus pneumoniae causes considerable morbidity and mortality in the elderly.
There are three established approaches to pneumococcal vaccination: polysaccharide …

Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies

E Amodio, C Costantino, S Boccalini… - Human vaccines & …, 2014 - Taylor & Francis
Streptococcus pneumoniae is a major cause of human infectious diseases worldwide.
Despite this documented evidence, data on pneumococcal disease rates among general …

A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: patient knowledge, awareness, and attitudes of vaccination and …

SA Baig, M Hassan, SM Ahmed… - Human Vaccines & …, 2014 - Taylor & Francis
Background: Pneumonia represents the leading cause of infection-related death and the fifth
cause of overall mortality, in the elderly. With increasing age, the human immune system …

Pneumococcal polysaccharide revaccination: immunoglobulin G seroconversion, persistence, and safety in frail, chronically ill older subjects

TE Lackner, RG Hamilton, JJ Hill… - Journal of the …, 2003 - Wiley Online Library
OBJECTIVES: To determine the 1‐month postpneumococcal polysaccharide‐revaccination
immunoglobulin G (IgG) antibody response, its persistence at 1 year, and tolerability of …

The epidemiology and biostatistics of pneumococcus

G Oligbu, NK Fry, SN Ladhani - Streptococcus pneumoniae: Methods and …, 2019 - Springer
Invasive infections caused by Streptococcus pneumoniae, such as pneumonia, meningitis,
and bacteremia, are a major cause of morbidity and mortality in young children and older …

Tissue targeted antigenic activation of the immune response to treat cancers

HD Gunn - US Patent 8,501,198, 2013 - Google Patents
G01N33/5008—Chemical analysis of biological material, eg blood, urine; Testing involving
biospecific ligand binding methods; Immunological testing involving human or animal cells …